Zobrazeno 1 - 10
of 151
pro vyhledávání: '"Anandwardhan A Hardikar"'
Autor:
Sandy R Shultz, Caroline J Taylor, Riemke Aggio-Bruce, William T O’Brien, Mujun Sun, Adrian V Cioanca, George Neocleous, Georgia F Symons, Rhys D Brady, Anandwardhan A Hardikar, Mugdha V Joglekar, Daniel M Costello, Terence J O’Brien, Riccardo Natoli, Stuart J McDonald
Publikováno v:
Biomarker Insights, Vol 17 (2022)
Introduction: Sports-related concussion (SRC) is a common form of brain injury that lacks reliable methods to guide clinical decisions. MicroRNAs (miRNAs) can influence biological processes involved in SRC, and measurement of miRNAs in biological flu
Externí odkaz:
https://doaj.org/article/6e5d1e47e8f3487faaf1d38c5e9fd355
Autor:
Emma S Scott, Rachel T McGrath, Andrzej S Januszewski, Daniel Calandro, Anandwardhan A Hardikar, David N O'Neal, Gregory Fulcher, Alicia J Jenkins
Publikováno v:
BMJ Open, Vol 9, Iss 12 (2019)
Objective To determine if continuous subcutaneous insulin infusion (CSII) therapy is associated with lower glycatedhaemoglobin (HbA1c) variability (long-term glycaemic variability; GV) relative to multiple daily injection (MDI) treatment in adults wi
Externí odkaz:
https://doaj.org/article/eedc699035514291bac3e348796fd150
Publikováno v:
PLoS ONE, Vol 5, Iss 1, p e8653 (2010)
Insulin-producing pancreatic islet beta cells (beta-cells) are destroyed, severely depleted or functionally impaired in diabetes. Therefore, replacing functional beta-cell mass would advance clinical diabetes management. We have previously demonstrat
Externí odkaz:
https://doaj.org/article/b1de418135764b8a9c66321aa40c807a
Autor:
Amaresh K Ranjan, Umesh Kumar, Ashutosh A Hardikar, Pankaj Poddar, Prabha D Nair, Anandwardhan A Hardikar
Publikováno v:
PLoS ONE, Vol 4, Iss 11, p e7718 (2009)
BACKGROUND:Coronary bypass graft failure as a result of acute thrombosis and intimal hyperplasia has been the major challenge in surgical procedures involving small-diameter vascular prosthesis. Coating synthetic grafts with patients' own endothelial
Externí odkaz:
https://doaj.org/article/cd17f0827c714948aa5d8dac9e78508b
Autor:
Mugdha V. Joglekar, Subhshri Sahu, Wilson K.M. Wong, Sarang N. Satoor, Charlotte X. Dong, Ryan J. Farr, Michael D. Williams, Prapti Pandya, Gaurang Jhala, Sundy N.Y. Yang, Yi Vee Chew, Nicola Hetherington, Dhan Thiruchevlam, Sasikala Mitnala, Guduru V. Rao, Duvvuru Nageshwar Reddy, Thomas Loudovaris, Wayne J. Hawthorne, Andrew G. Elefanty, Vinay M. Joglekar, Edouard G. Stanley, David Martin, Helen E. Thomas, David Tosh, Louise T. Dalgaard, Anandwardhan A. Hardikar
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 13, Iss 5, Pp 1530-1553.e4 (2022)
Background & Aims: Pancreatic islet β-cells are factories for insulin production; however, ectopic expression of insulin also is well recognized. The gallbladder is a next-door neighbor to the developing pancreas. Here, we wanted to understand if ga
Externí odkaz:
https://doaj.org/article/3d728a223a8941f1b6deb7467c5a4e8a
Publikováno v:
American Journal of Physiology-Cell Physiology. 323:C367-C377
The microRNA-29 family members miR-29a-3p, miR-29b-3p, and miR-29c-3p are ubiquitously expressed and consistently increased in various tissues and cell types in conditions of metabolic disease, obesity, insulin resistance, and type 2 diabetes. In pan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be4431a964ad27aa55fccf3b3b385348
https://doi.org/10.1152/ajpcell.00051.2022
https://doi.org/10.1152/ajpcell.00051.2022
Autor:
Michael D. Williams, Mugdha V. Joglekar, Sarang N. Satoor, Wilson Wong, Effie Keramidaris, Amanda Rixon, Philip O’Connell, Wayne J. Hawthorne, Geraldine M. Mitchell, Anandwardhan A. Hardikar
Publikováno v:
Cell Transplantation, Vol 28 (2019)
Type 1 diabetes (T1D) is characterized by the loss of insulin-producing β-cells in the pancreas. T1D can be treated using cadaveric islet transplantation, but this therapy is severely limited by a lack of pancreas donors. To develop an alternative c
Externí odkaz:
https://doaj.org/article/0a0f327432b448eb9698288256c10dcb
Autor:
Matthew B. O'Rourke, Andrzej S. Januszewski, David R. Sullivan, Imre Lengyel, Alan J. Stewart, Swati Arya, Ronald C. Ma, Sanjeev Galande, Anandwardhan A. Hardikar, Mugdha V. Joglekar, Anthony C. Keech, Alicia J. Jenkins, Mark P. Molloy
Funding: This work was performed by funding from The University of Sydney (CIA Jenkins) and funds provided by the National Health and Medical Research Council (Australia) APP1147897. Purpose: Robust, affordable plasma proteomic biomarker workflows ar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02655d11181085ba624787daffb21aa1
https://hdl.handle.net/10023/27246
https://hdl.handle.net/10023/27246
Autor:
Sahar I. Da’as, Ikhlak Ahmed, Waseem H. Hasan, Doua A. Abdelrahman, Elbay Aliyev, Sabah Nisar, Ajaz Ahmad Bhat, Mugdha V. Joglekar, Anandwardhan A. Hardikar, Khalid A. Fakhro, Ammira S. Al-Shabeeb Akil
Publikováno v:
Journal of Translational Medicine. 21
Background Type 2 diabetes (T2D) is a critical healthcare challenge and priority in Qatar which is listed amongst the top 10 countries in the world, with its prevalence presently at 17% double the global average. MicroRNAs (miRNAs) are implicated in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b15321ed0e3bcc5140728c4d2f11c99
https://doi.org/10.1186/s12967-023-03893-2
https://doi.org/10.1186/s12967-023-03893-2
Autor:
Feifei Cheng, Andrea O. Luk, Mai Shi, Chuiguo Huang, Guozhi Jiang, Aimin Yang, Hongjiang Wu, Cadmon K.P. Lim, Claudia H.T. Tam, Baoqi Fan, Eric S.H. Lau, Alex C.W. Ng, Kwun Kiu Wong, Luke Carroll, Heung Man Lee, Alice P. Kong, Anthony C. Keech, Elaine Chow, Mugdha V. Joglekar, Stephen K.W. Tsui, Wing Yee So, Hon Cheong So, Anandwardhan A. Hardikar, Alicia J. Jenkins, Juliana C.N. Chan, Ronald C.W. Ma
Publikováno v:
Diabetes Care. 45:701-709
OBJECTIVE Several studies support associations between relative leukocyte telomere length (rLTL), a biomarker of biological aging and type 2 diabetes. This study investigates the relationship between rLTL and the risk of glycemic progression in patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21a7fa42e6b29e2d456bcac5bd6458fc
https://doi.org/10.2337/dc21-1609
https://doi.org/10.2337/dc21-1609